Last reviewed · How we verify
conventional migraine drug treatment
Conventional migraine drugs work through multiple mechanisms including vasoconstriction, serotonin receptor modulation, and pain pathway inhibition to relieve acute migraine symptoms.
Conventional migraine drugs work through multiple mechanisms including vasoconstriction, serotonin receptor modulation, and pain pathway inhibition to relieve acute migraine symptoms. Used for Acute migraine with or without aura, Migraine prophylaxis (for certain agents).
At a glance
| Generic name | conventional migraine drug treatment |
|---|---|
| Sponsor | Birjand University of Medical Sciences |
| Drug class | Triptan, ergot alkaloid, or NSAID (class varies by specific agent) |
| Target | 5-HT1B/1D receptors (triptans); COX inhibition (NSAIDs); or alpha-adrenergic/serotonergic receptors (ergots) |
| Modality | Small molecule |
| Therapeutic area | Neurology |
| Phase | FDA-approved |
Mechanism of action
Conventional migraine treatments typically include triptans (5-HT1B/1D receptor agonists causing cranial vasoconstriction), ergot alkaloids, and NSAIDs that reduce inflammation and pain signaling. These agents target the trigeminal system and cerebral blood vessels to abort migraine attacks or prevent their progression. The specific mechanism depends on the drug class used, ranging from direct vasoconstrictive effects to modulation of neuropeptide release.
Approved indications
- Acute migraine with or without aura
- Migraine prophylaxis (for certain agents)
Common side effects
- Chest pain or pressure
- Dizziness
- Nausea
- Flushing
- Tingling or paresthesia
- Fatigue
Key clinical trials
- Integrative and Complementary Therapy for Episodic Migraine and Tension-type Headache
- Magnesium Versus Prochlorperazine Versus Metoclopramide for Migraines (PHASE3)
- Efficacy of Greater Occipital Nerve Radiofrequency for Refractory Migraine Treatment
- Precutaneous High Risk Patent Foramen Ovale to Treat Migraine Headaches (PHASE2)
- Cupping and Serkangabin Versus Conventional Migraine Treatment (PHASE4)
- Acupuncture in Chronic Migraine: A Randomized Controlled Trial (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: